MOFFITT STAR Trademark

Trademark Overview


On Tuesday, April 26, 2022, a trademark application was filed for MOFFITT STAR with the United States Patent and Trademark Office. The USPTO has given the MOFFITT STAR trademark a serial number of 97381872. The federal status of this trademark filing is REGISTERED as of Tuesday, April 25, 2023. This trademark is owned by H. Lee Moffitt Cancer Center and Research Institute, Inc.. The MOFFITT STAR trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical testing for diagnostic or treatment purposes in the field of cancer and infectious diseases using an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA; Medical testing services relating to the diagnosis and treatment of disease

Laboratory research in the field of genomics and immuno-oncology, namely, product development in the nature of development of diagnostic molecular testing for analyzing disease and genome information, in particular an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA from cancer cells to detect mutations therein and provide assessment and information about such mutations for the purpose of evaluating and screening patients for clinical trials in planning medical treatment for and providing targeted therapy selection to cancer patients
moffitt star

General Information


Serial Number97381872
Word MarkMOFFITT STAR
Filing DateTuesday, April 26, 2022
Status700 - REGISTERED
Status DateTuesday, April 25, 2023
Registration Number7036963
Registration DateTuesday, April 25, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Goods and ServicesMedical testing for diagnostic or treatment purposes in the field of cancer and infectious diseases using an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA; Medical testing services relating to the diagnosis and treatment of disease
Goods and ServicesLaboratory research in the field of genomics and immuno-oncology, namely, product development in the nature of development of diagnostic molecular testing for analyzing disease and genome information, in particular an enrichment-based diagnostic NGS (Next Generation Sequencing) testing panel assay used for extracting and sequencing nucleic acid, DNA, RNA from cancer cells to detect mutations therein and provide assessment and information about such mutations for the purpose of evaluating and screening patients for clinical trials in planning medical treatment for and providing targeted therapy selection to cancer patients

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code042
First Use Anywhere DateMonday, February 5, 2018
First Use In Commerce DateMonday, February 5, 2018

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 2, 2022
Primary Code044
First Use Anywhere DateMonday, February 5, 2018
First Use In Commerce DateMonday, February 5, 2018

Trademark Owner History


Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTampa, FL 33612

Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33612

Party NameH. Lee Moffitt Cancer Center and Research Institute, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33612

Trademark Events


Event DateEvent Description
Tuesday, April 25, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 25, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 2, 2022NON-FINAL ACTION E-MAILED
Friday, December 2, 2022NON-FINAL ACTION WRITTEN
Thursday, November 3, 2022ASSIGNED TO EXAMINER
Monday, May 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 29, 2022NEW APPLICATION ENTERED